Explore

The fast-acting drug offers a new way to treat depression and fathom its origins. Recent approval of a nasal spray promises to expand access, but much remains unknown.
  • Knowable Magazine
Chance observations in the 1950s prompted scientists to hypothesize that low neurotransmitter levels cause depression. That thinking has unraveled.
  • Knowable Magazine
In response to the rising opioid epidemic, neuroscience researchers worldwide are working to develop new treatments for chronic pain.
  • BrainFacts/SfN
Learn about the reward prediction error hypothesis as it applies to addiction and reward cues in thebrain.
  • BrainFacts/SfN
  • 5 min
As Zachary Pennington watched friends and family grapple with substance dependency and anxiety disorders, he knew he wanted to find a way to help.
  • BrainFacts/SfN
What can the flick of a rat’s tail tell us about opioid addiction? More than you might think.
  • BrainFacts/SfN
Learn how the neurotransmitter dopamine contributes to substance use disorder.
  • BrainFacts/SfN
  • 4 min
Let's view a journey into your brain as a young neuron and his professor do their best to explain how addiction works in their own ways.
  • BrainFacts/SfN
  • 4 min
Can we use the brain’s natural marijuana-like compounds to alleviate PTSD, chronic pain, and other debilitating disorders?
  • BrainFacts/SfN
By targeting pain at its source, scientists are aiming to develop new and safer pain relievers.
  • BrainFacts/SfN
People who react strongly to placebos also react strongly to antidepressants, and vice versa, according to new research.
  • The Dana Foundation
A roundtable of scientists discuss ongoing research on the effects and potential applications of marijuana for adolescents in the United States.
  • Science Friday
  • 29 min